METTL3 and neoplasm: METTL3 was located in the nuclei of tumour cells and tumour-infiltrating immune cells, while CD33+ cells were scattered mainly in the tumour stroma (Fig. 1a, b); isotype IgG was used as a control (Fig. 1c).